“HIGH-DOSE-RATE BRACHYTHERAPY FOR PROSTATE CANCER: DIRECT IN VIVO DOSIMETRY IS AN IMPORTANT FACTOR IN INCREASING THE EFFECTIVENESS OF TREATMENT AND REDUCING THE INCIDENCE OF COMPLICATIONS” (2019) Voprosy onkologii, 65(4), pp. 596–602. doi:10.37469/0507-3758-2019-65-4-596-602.